Our experimental data, including transcriptome analysis for paired NAFs and CAFs, demonstrated that CAFs secreted significantly higher amounts of IL-6 than NAFs, and thus, CAFs are more likely to contribute to chemotherapeutic resistance in GC cells than NAFs. Here, IL6 is linked to gastric cancer.